Introduction {#S0001}
============

The number of patients hospitalized due to hip fracture has been reported to be 620,000 in the European Union in 2010 and 210,000 per year between 2008 and 2011 in the United States.[@CIT0001],[@CIT0002] It is the dominant cause of trauma-related mortality in people above 65 years, and among the survivors, 50% never reached their previous functional level.[@CIT0003]--[@CIT0006] Moreover, hip fracture is related to considerable healthcare costs.[@CIT0007]--[@CIT0009] Previous research has indicated variation in outcome after hip fracture and only a slight improvement in survival over time.[@CIT0010]--[@CIT0012] Western healthcare systems have therefore developed clinical guidelines for hip fracture care and countries including Sweden, Norway, Finland, Denmark and the United Kingdom have initiated continuous monitoring of the quality of care after hip fracture.[@CIT0013],[@CIT0014]

The Danish Multidisciplinary Hip Fracture Registry (DMHFR) was initiated in 2003 as part of a national quality improvement project called the Danish National Indicator Project.[@CIT0015] The aim of the DMHFR is to monitor and support implementation of evidence-based clinical guidelines for hip fracture care and ultimately improve the quality and outcome of hip fracture patients. The registry has a multidisciplinary steering committee appointed by the Danish regions, the Danish Orthopedic Society, the Danish Geriatric Society, the Danish Nurses Organization and the Danish Society for Physiotherapists.[@CIT0016] The steering committee chose quality of care indicators, including process performance measures and outcome, as well as descriptive prognostic variables, which reflect current evidence-based approaches within multidisciplinary hip fracture care and their feasibility in clinical practice. The DMHFR is part of the umbrella organization Danish Clinical Registries, and the results are publically available in an annual report in aggregated form.[@CIT0016]

Aim {#S0002}
===

The present paper aims to describe the organization and content of the DMHFR, to present results regarding demographics and quality indicators during the period 2006--2018 and to illustrate the potential of the DMHFR for clinical epidemiological research.

Materials and Methods {#S0003}
=====================

Setting {#S0003-S2001}
-------

Denmark is a country with 5.7 million inhabitants with free access to medical care and a longstanding tradition for health-care registries.[@CIT0017] All patients with hip fracture are admitted to the nearest public hospital treating acute patients. All inhabitants have a unique civil registration number, which is used in all healthcare contacts and allows unambiguous linkage between the healthcare registries.[@CIT0018]

Data Collection Procedures {#S0003-S2002}
--------------------------

Reporting to the DMHFR is mandatory by law for all hospitals from 2006.[@CIT0019] During the period from 2006 to 2018 all hospitals treating hip fracture patients were reporting to the registry. Data are prospectively collected on an individual-level by healthcare professionals involved in treatment of hip fracture patients from the time of hospital admission to discharge, covering different aspects of the clinical pathway. Detailed data definitions are developed prior to data collection. Fulfillment of the process performance measures are registered by the staff members prospectively as part of the clinical routine and are reported monthly to the registry. From 2004 to March 2010 the registry was a web-based standalone database, as data were collected using an independent web-based interface. From March 2010 and forward, the registry uses routine collected data retrieved directly from the Danish National Patient Registry to avoid double registration by clinicians.[@CIT0020]

Study Population {#S0003-S2003}
----------------

The DMHFR includes patients' age ≥65 admitted acutely with a femoral neck, pertrochanteric (intertrochanterica femoris or trochanterica femoris) or subtrochanteric fracture ([Figure 1](#F0001){ref-type="fig"}) and treated surgically with osteosynthesis or total/hemi arthroplasty.Figure 1Types of collum femoris fractures included in the multidisciplinary hip fracture registry.

Main Variables {#S0003-S2004}
--------------

### Quality Indicators {#S0003-S2004-S3001}

A documentary report, which reflects current evidence within multidisciplinary hip fracture care, is developed. On the basis of this evidence-based approach as well as feasibility in clinical practice, quality of care indicators are developed. The quality indicators in the DMHFR include process performance measures and outcome measures. Eight process performance measures are currently available and include timing of preoperative optimization, surgery delay (24 and 36 hours), mobilization within 24 hours, assessment of nutrition status, basic mobility score pre- and postoperative, rehabilitation program, osteoporosis- and fall prophylaxis. The process performance measures reflect key recommendations for healthcare processes, which are expected to be associated with patient outcome. The staff members classify the patient as eligible or non-eligible for the process performance measures according to detailed data definitions. Subsequently, the staff members register fulfillment or non-fulfillment of the measure. Missing registration of fulfillment would be coded as a non-fulfillment of the process performance measure.

Currently, three outcome measures are available: Survival within 30 days, readmission within 30 days after discharge and reoperation within two years. Due to the individual-level record linkage to other public registries and the civil registry number in Denmark, complete follow-up for every patient is possible for the outcome measures. Information on survival is obtained from the Civil Registration System, which has daily updated electronic records of all changes in vital status for the entire Danish population since 1968.[@CIT0018] Readmission is defined as an acute first time readmission to any hospital 24 hours after discharge from hip fracture with a length of stay of minimum 24 hours. Reoperation is defined in four different ways depending on fracture type and surgery type. Information on readmission and reoperation is obtained from the Danish National Patient Registry, which is a nationwide administrative registry that covers all admissions and discharges from Danish somatic hospitals since 1977. Since 1994, up to 20 diagnoses for every discharge are coded according to the Danish version of the International Classification of Diseases tenth edition.[@CIT0020]

The core of the quality of care indicators has been quite consistent in the first ten years. However, demands for fulfillment of some process performance measures have increased over time and data definitions were adjusted. For instance, a timestamp for mobilization within 24 hours was implemented in 2015. Before 2015, the clinicians reported whether the patient was mobilized within 24 hours with the answer yes or no. After 2015, clinicians have reported the exact time for first mobilization. Likewise, in 2013, fulfillment of the measure basic mobility assessment presupposes that the CAS score value also was reported. Moreover, new quality indicators have been added by the steering committee regularly. Detailed specifications for the individual indicator calculation are publicly available through the Danish Clinical Registry's website.[@CIT0016] A description of the measures used in the registry is presented in [Table 1](#T0001){ref-type="table"}.Table 1The Quality Indicators in the Multidisciplinary Hip Fracture Registry Through the YearsIndicator AreaIndicator2006200720082009201020112012201320142015201620172018Process Performance MeasuresPain assessmentDaily systematic pain assessment using a visual analog scale or a numeric rating scale at rest and during mobilization+++++++++Mobilization within 24 hoursBeing mobilized within 24 hours postoperatively, defined as assisting the patient from bed rest to walking or rest in a chair++++++^a^+++Assessment of nutrition riskAssessment of patients BMI and nutritional risk within two days after admission.++++++++Osteoporotic medicationEvaluation of need of anti-osteoporotic medications, which includes continued anti-osteoporosis medication, no indication for treatment due to cancer or psychiatric condition or referring to DEXA scan+++++++++Fall preventionInitiation of treatment to prevent future fall accidents, including a fall risk assessment to account for co-existing medical conditions, medication, functional disability, symptoms from the central nervous system, musculoskeletal system and cardiopulmonary status+++++++++Prevention of osteoporotic fracturesInitiation of treatment includes ordination of any anti-osteoporotic medications or calcium and d-vitamin or hip protectors++++Post discharge rehabilitation programPost discharge rehabilitation program including assessment of activities of daily living (ADL) with a validated test before the fracture and again before discharge++++++++++++Assessment of functional level prior to admissionBasic mobility assessment using a validated test such as Cumulated Ambulation Score (CAS), Barthel 20, Functional Recovery score or New Mobility score. From 2013, only CAS is measured at admission.+++++^a^+++^a^+++++Assessment of functional level at dischargeBasic mobility assessment using a validated test such as Cumulated Ambulation Score (CAS), Barthel 20, Functional Recovery score or New Mobility score. From 2013, only CAS is measured prior to discharge+++++++++++++Surgical delayPatient had surgery within 24 hours after admission to hospital (from 2016, admission time was changed to arrival time)++++Patient had surgery within 36 hours after admission to hospital (from 2016, admission time was changed to arrival time)++++Preoperative optimizationAssessment by a medical specialist intending to do a preoperative optimization plan within four hours after arrival to the hospital.+++Outcome Measures30-day survivalSurvival within 30 days after surgery date+++++++++++++Reoperation within two years after osteosynthesisReoperation within two years among patients, who have had a medial femoral fracture treated with osteosynthesis regardless of fracture displacement+++++++++++++Reoperation within two years among patients, who have had a medial undisplaced femoral fracture treated with osteosynthesis.+++++++++++++Reoperation within two years among patients, who have had a medial displaced femoral fracture treated with osteosynthesis regardless of fracture displacement+++++++++++++Reoperation within two years among patients, who have had a pertrochanter or subtrochanter femoral fracture treated with osteosynthesis.Reoperation within two years after alloplasticReoperation within two years among patients, who have had an alloplastic regardless of fracture type+++++++++++++Reoperation within two years due to infectionReoperation within two years due to deep infection+++++++++++++Acute readmission within 30-days after dischargeAcute readmission to any Danish hospital regardless of cause within 30 days after discharge with the hip fracture diagnosis+++[^1]

Local and regional audits on quality indicators are carried out every third month. Further, the steering committee performs an annually structured audit process and publishes an annual report followed by comments and recommendations from the audits on how to improve quality of care.

### Descriptive Variables {#S0003-S2004-S3002}

The DMHFR has information on a number of patient- and surgery-related variables, which, based on the current evidence, appear to be well-established prognostic factors. Patient-related variables included admission age, sex, Body Mass Index (BMI) and residence. In the period from 2005 to 2010 information on alcohol intake and smoking were collected. The surgery-related variables included type of fracture, fracture displacement, and type of surgery ([Table 2](#T0002){ref-type="table"}). In the period from 2005 to 2010, information on the American Society of Anesthesiologists' (ASA) classification score was collected. From 2010 and onward, the ASA score was replaced with the Charlson Comorbidity Index (CCI). The CCI is a method of categorizing comorbidities of patients based on ICD diagnosis codes from the Danish National Patient Registry.[@CIT0021] Surgical delay was included in the DMHFR as a prognostic factor in the period 2006 to 2014 and as a process performance measure since 2015.Table 2Patient Characteristics of the Hip Fracture Population from 2006 to 20182006200720082009201020112012201320142015201620172018Number of Admissions6456656674237155514371586801690466116789667965026374Age, median year (Q1-Q3)8383848483 (77--89)83(77--89)84(78--89)84(77--89)84(77--89)83(77--89)84(77--89)83(77--89)83(76--89)Gender: Men1686178419981939141320381970198818672021206020352045 Women4770478254255216373051204831491647444768461944674329Residence (2005--2009): Living together with another adult1673168619691914 Living alone in one's own home3244334439463802 Other including living in a nursing home or other institution1060121612561158 Missing479320252281Residence (2010→) Own home287147914540471744574599460944004501 Own home affiliated with an institution378424385405360378391257217 Institution87113111227135711821080114711121136 Missing1023632649425612732532733520ASA: (2006--2009) 0602543570546 12977318935383582 22091220725752383 4338357336311 51012129 Missing438258392324CCI (2010→): None 0 point20232800254423992512242023942307 Mild 1 point12011723171815911510155414971441 Moderate 2 points9031266119211541229119911821151 Severe ≥ 3 points10161369145014671538150614291475BMI (2010→): \< 19: Underweight58696195810309438811426795829 20--25: Normal177029192850291628112757264424282327 26--29: Overweight87115401383145514101484147613941334 \>30: Obese323412375429399402478461430 Missing15931326123510741048105565514241454Fracture Displacement Displaced4707537561845880314253144985520248455081481142663792 Undisplaced932114912091243549835787828744680657542464 Unspecified81742303214521009102987410221028121116942118Type of Fracture Medial femoral neck3253333437863597266236713619381536303781369134983371 Pertrochanteric2628272130752966209329492704259327142526250224952527 Subtrochanteric410484551577388538478496526482486509476 Missing165271115Type of Surgery Osteosynthesis4597473453095018353848774435446443364365432541764082 Hemi/total arthroplasty1572161119451964160522812366244022752424235423262292 Missing287221169173Alcohol Intake (2006--2009) ≤ 14/21 per week for women/men4405480157595307 \>14/21 units per week for women/men188230272230 Missing1863153513921618Smoking Habits (2006--2009) Current1366141216571532 Former1001115114221401 Never2180243128372516 Missing1909157215071706Time to Surgery (hours)^a^ \<24 hours329334053855390128583899429943924377 24-48 hours219721042502228615842361187618901827 \> 48 hours759781858714693893626617402 Missing2072762082548555Region North Denmark925872852606913844765783769800804702 Central Denmark160716751628109715131455150914211454144914191428 Southern Denmark184418181757119617141566156616071556155915661670 Capital region134317801791143419491898191717771871177016181495 Zeeland region10791142112781010691038114710231139110110951079[^2][^3]

Results {#S0004}
=======

Patient Characteristics {#S0004-S2001}
-----------------------

During the period 2006--2018, the DMHFR included 87,803 hip fracture patients. The number of patients varied slightly during the study period, but the average was 6,800 patients ([Table 2](#T0002){ref-type="table"}). The majority of hip fracture patients are women with a median age of 84 years, living alone. The most frequent fracture type is a femoral neck fracture and the most frequent surgery type is internal fixation. The proportion of hip fracture patients with comorbidity has increased over time ([Table 2](#T0002){ref-type="table"}).

Quality Indicators {#S0004-S2002}
------------------

### Process Performance Measures {#S0004-S2002-S3001}

For the process performance measures, improvement over the years has been observed for most of the measures even though the demands for fulfillment of the process performance measures have increased over the period ([Figure 2](#F0002){ref-type="fig"}). An exception is the process performance measures implemented in 2015, including preoperative optimization and surgery within 24 and 36 hours respectively, where the fulfillment has not improved over the three years. A decrease in fulfillment of some of the process performance measures such as mobilization within 24 hours in 2015 and basic mobility assessment in 2013 may be related to change in data definitions ([Figure 2](#F0002){ref-type="fig"}).Figure 2Proportion of patients in percent that have fulfilled the individual process performance measures over time.

Outcome Measures 30-Day Mortality, Readmission and Reoperation {#S0004-S2003}
--------------------------------------------------------------

The overall 30-day survival varied from 90% to 88% during 2006--2018. The proportion of patients that were re-operated within two years has decreased over the study period, from 27% to 13% among patients with a displaced medial femoral neck fracture, and from 15% to 9% among patients with un-displaced medial fracture ([Figure 3](#F0003){ref-type="fig"}). Reoperations among patients treated with an arthroplasty were highest in the period from 2008 to 2011 with around 13%, and have decreased to 9% subsequently. Almost 1820% of patients were readmitted within 30 days during 2015 to 2018.Figure 3Proportion of patients with 30-day survival and readmission and reoperation within two years over time.

Examples of Research {#S0004-S2004}
--------------------

The DMHFR data are accessible for research after application to the Danish Clinical Registries.[@CIT0016] Published papers are based on the DMHFR data linked to other Danish health registries, including the Danish National Patient Registry, the Civil Registration System, the Danish Transfusion Database, the Danish Prescription Database, the Laboratory Information System, and the Integrated Database for Labour Marked Research. The studies have focused on variation in the outcome measures among patient types and hospitals.[@CIT0022]--[@CIT0024] An association between fulfillment of the process performance measures and better survival and lower readmission rate has been found[@CIT0025]--[@CIT0028] as well as an association between orthogeriatric specialization or patient volume and outcome.[@CIT0029]--[@CIT0031] In addition, associations between transfusion practice and outcome,[@CIT0032],[@CIT0033] association between surgery delay and post-operative complications,[@CIT0034],[@CIT0035] associations between some commonly used medication preoperatively, including antidepressants, anticoagulants and anti-inflammatory drugs and post-operative complications[@CIT0036]--[@CIT0040] have been observed. Moreover, studies have found that about 15% of hip fracture patients develop an acute kidney injury within 5 days of surgery[@CIT0041],[@CIT0042] and about 15% of patients sustain post-operative infections within 30 days of surgery,[@CIT0043],[@CIT0044] complications which are strongly associated with 30 days mortality. Besides, hip fracture patients were at increased excess risk of venous thromboembolism, myocardial infarction and stroke up to one year following fracture.[@CIT0045],[@CIT0046]

Discussion {#S0005}
==========

The DMHFR is a nationwide registry established in 2003 with the aim of monitoring and improving hip fracture treatment and care in Denmark. The hip fracture population in Denmark is characterized by a median age of 84 years and a high completeness of reporting. The quality of treatment and care reflected by receiving guideline recommended recommendations has increased over the years. The 30-day survival has improved from 88% to 90% in the period. The proportion of reoperations has decreased especially among patients with medial femoral neck fracture. In contrast, the risk for acute readmission has increased from 16% to 20% in the last three years.

Comparison with Other Hip Fracture Registries {#S0005-S2001}
---------------------------------------------

Continuous monitoring of the quality of healthcare has been implemented in many European countries[@CIT0014] including Finland (PERFormance, Effectiveness and Cost of Treatment episodes),[@CIT0047] Sweden (Rikshöft),[@CIT0048] the United Kingdom (UK) (the National Hip Fracture Database),[@CIT0013],[@CIT0049] Scotland (the Scottish Hip Fracture Audit),[@CIT0050] Italy (Regional Outcome Evaluation Program in the Lazio region[@CIT0051] and Gruppo Italiano di Ortogeriatria),[@CIT0052] Norway (The Norwegian Hip Fracture Registry),[@CIT0053] Spain (National Hip Fracture Registry),[@CIT0054] Ireland (Irish Hip Fracture database),[@CIT0055] Nederlands (Dutch National Hip Fracture Audit),[@CIT0056] Germany (Alterstrauma register),[@CIT0057] and Denmark (DMHFR). However, the majority of these registries[@CIT0047],[@CIT0050],[@CIT0051],[@CIT0053]--[@CIT0055] mainly monitor outcome performance measures, eg, mortality and readmissions at the hospital level, and lack continuous monitoring of process performance measures. Exceptions are the DMHFR, Rikshöft[@CIT0048] and the National Hip Fracture Database in the UK,[@CIT0013],[@CIT0049] which contain valuable information on process performance measures according to clinical guideline recommendations. The measures monitored in the National Hip Fracture Database in the UK are comparable to the process performance measures as they monitor mobilization on the first postoperative day, bone-protection medication and geriatric assessment. The fulfillment of the process performance measures is generally higher in the UK compared to Denmark, eg, 69% were mobilized on the first operative day in Denmark whereas 79% were mobilized in the UK. Likewise is the survival lower in Denmark compared to the UK and Sweden, as they report an overall 30-day mortality rate below 8% compared to 10% in Denmark.[@CIT0058],[@CIT0059] The lower mortality may be explained by different inclusion criteria in the hip fracture registries, eg, different inclusion ages, which may impact the risk of mortality. For instance, the Scottish Hip Fracture Audit, the Swedish Rikshöft registry and the Finish PERFECT registry include hip fracture patients from 50 years, whereas the Danish Multidisciplinary hip fracture registry includes patients from 65 years.

Perspective {#S0005-S2002}
-----------

The efforts are on-going to improve the fulfillment of the process performance measures and thereby improve the hip fracture patients´ survival. The completeness of registered variables for each patient is high, however an in-depth validation of the data in the DMHFR with focus on completeness and positive predictive value of the registered data needs to be done. The length of hospital stay has decreased, which includes earlier discharge to care in the community settings or at home with support from home care or mobile rehabilitation units. The hip fracture registries therefore need data from the community setting including primary healthcare services to improve our knowledge on the full clinical pathway of hip fracture patients and it impact on the patient outcome.

Administrative Issues and Funding {#S0005-S2003}
---------------------------------

The clinicians reporting to the registry have no economic incentives, but there is an increasing interest from politicians, hospital boards of directors and patient organizations regarding fulfillment of the quality indicators. DMHFR is funded by the Danish Regions and receives epidemiological, statistical and administrative support from the Danish Clinical Registries (RKKP), which has a budget of 9.9 million USD to operate 80 databases in Denmark. DMHFR receives 16,000 USD yearly for holding audits, multidisciplinary seminars and revising data definitions. The DMHFR is approved as a national clinical quality database by the National Board of Health and the Data Protection Agency. Permission to access the data from the DMHFR has been granted by the Data Protection Agency and the steering Committee following an application to the Data Protection Agency and RKKP.

Conclusion {#S0006}
==========

The DMHFR plays an important key role in monitoring and improving hip fracture care in Denmark due to prospectively collected high-validity data. Furthermore, the DMHFR has been linked to a wide range of other national registries in order to answer a number of relevant clinical questions regarding the treatment and outcome of hip fracture patients. Thus, the DMHFR is a valuable tool for both quality improvement and epidemiological research.
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[^1]: **Note:** ^a^Change in data definitions.

[^2]: **Note:** ^a^From 2015 and onward time to surgery is collected as a process performance measure.

[^3]: **Abbreviations:** BMI, Body Mass Index; ASA, American Society of Anesthesiologists' classification score; CCI, Charlson Comorbidity Index.
